Dr. Amy Novatt delves into the complex and often misunderstood realm of menopause hormonal therapy, previously known as Hormone Replacement Therapy (HRT). Dr. Novatt is joined by Dr. Liz Lyster, an OB-GYN and midlife health expert, to discuss the history, controversies, and current understanding surrounding hormone therapy. The conversation includes an in-depth look at the impact of the landmark 2002 Women's Health Initiative (WHI) study, which drastically changed the public perception and medical approach to HRT, and moves on to explore bio-identical hormones, safer methods of administration, and the importance of individualized treatment plans.

Dr. Lyster provides expert insights into the benefits of hormone therapy, including its role in alleviating menopausal symptoms, improving bone density, and potentially lowering the risks of heart disease, dementia, and certain cancers. Both hosts emphasize the significance of personalized medical advice and the need to consider each woman's unique health profile and family history. The episode also covers practical advice on when to start hormone therapy, the importance of a baseline bone density scan at age 50, and the often misunderstood concept of 'estrogen dominance.' They encourage listeners to proactively engage with their healthcare providers and to consider hormone therapy as a viable option for improving quality of life during the menopausal transition.

On a more personal note, Dr. Lyster shares her recent experiences with loss and grief. This segment underscores the broader theme of reinvention and resilience during midlife, touching on how managing one's health can help navigate the emotional and physical changes that accompany this stage of life.

Questions of comments?

Produced by Jennifer Hammoud and Matty Rosenberg @ Radio Free Rhiniecliff